| Filed On | Filing |
|---|---|
| 24 May 2024 |
Form 4/A: Liu Margaret, Director
Granted 16,500 Employee Stock Option (right to buy) |
| 20 May 2019 |
Form 4/A: Siegel Jay Philip, Director
Granted 10,000 Stock Option (right to buy) |
| 26 Jan 2018 |
Form 4/A: Risser Eric Blasius, Sr VP & Chief Business Officer
Received 3,000 shares by exercise or conversion ($2.82K) · Sold 3,000 shares ($67.5K) |
| 19 Oct 2016 |
Form 4/A: Wigginton Jon Marc, Sr VP, Clinical Dev. & CMO
Received 10,000 shares by exercise or conversion ($47K) · Sold 10,000 shares ($293K) |
| 01 Jun 2016 |
Form 4/A: Saran Atul, SVP & General Counsel
Gave up 1,862 shares to cover exercise price or tax ($38.8K) |
| 07 Oct 2015 |
Form 4/A: Wigginton Jon Marc, Sr VP, Clinical
Received 5,000 shares by exercise or conversion ($23.5K) · Sold 5,000 shares ($106K) |
| 07 Oct 2015 |
Form 4/A: Wigginton Jon Marc, Sr VP, Clinical
Received 10,000 shares by exercise or conversion ($47K) · Sold 10,000 shares ($372K) |
| 01 Jul 2015 |
Form 4/A: Bonvini Ezio, Senior VP, Research
Received 6,097 shares by exercise or conversion ($4.33K) · Sold 6,097 shares ($232K) |
| 01 Jul 2015 |
Form 4/A: Bonvini Ezio, Senior VP, Research
Received 13,054 shares by exercise or conversion ($9.27K) · Sold 13,054 shares ($498K) |
Loading...
